vs

Side-by-side financial comparison of DIVERSIFIED HEALTHCARE TRUST (DHC) and IDEAYA Biosciences, Inc. (IDYA). Click either name above to swap in a different company.

DIVERSIFIED HEALTHCARE TRUST is the larger business by last-quarter revenue ($379.6M vs $207.8M, roughly 1.8× IDEAYA Biosciences, Inc.). IDEAYA Biosciences, Inc. runs the higher net margin — 57.4% vs -5.6%, a 63.0% gap on every dollar of revenue. IDEAYA Biosciences, Inc. produced more free cash flow last quarter ($142.2M vs $-166.4M).

GE Healthcare Technologies, Inc. is an American health technology company based in Chicago, Illinois. The company, which stylizes its own name as GE HealthCare, operates four divisions: Medical imaging, which includes molecular imaging, computed tomography, magnetic resonance, women’s health screening and X-ray systems; Ultrasound; Patient Care Solutions, which is focused on remote patient monitoring, anesthesia and respiratory care, diagnostic cardiology, and infant care; and Pharmaceutical ...

IDEAYA Biosciences, Inc. is a clinical-stage biotechnology company focused on oncology, developing targeted therapies and synthetic lethality treatments for patients with genetically defined cancers. It advances a pipeline of candidates across multiple tumor types, partnering with industry stakeholders to accelerate global access to innovative cancer care solutions.

DHC vs IDYA — Head-to-Head

Bigger by revenue
DHC
DHC
1.8× larger
DHC
$379.6M
$207.8M
IDYA
Higher net margin
IDYA
IDYA
63.0% more per $
IDYA
57.4%
-5.6%
DHC
More free cash flow
IDYA
IDYA
$308.6M more FCF
IDYA
$142.2M
$-166.4M
DHC

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
DHC
DHC
IDYA
IDYA
Revenue
$379.6M
$207.8M
Net Profit
$-21.2M
$119.2M
Gross Margin
Operating Margin
-12.6%
52.2%
Net Margin
-5.6%
57.4%
Revenue YoY
-0.0%
Net Profit YoY
75.7%
330.1%
EPS (diluted)
$-0.09
$1.33

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DHC
DHC
IDYA
IDYA
Q4 25
$379.6M
Q3 25
$388.7M
$207.8M
Q2 25
$382.7M
Q1 25
$386.9M
Q4 24
$379.6M
Q3 24
$373.6M
$0
Q2 24
$371.4M
$0
Q1 24
$370.8M
$0
Net Profit
DHC
DHC
IDYA
IDYA
Q4 25
$-21.2M
Q3 25
$-164.0M
$119.2M
Q2 25
$-91.6M
Q1 25
$-9.0M
Q4 24
$-87.4M
Q3 24
$-98.7M
$-51.8M
Q2 24
$-97.9M
$-52.8M
Q1 24
$-86.3M
$-39.6M
Operating Margin
DHC
DHC
IDYA
IDYA
Q4 25
-12.6%
Q3 25
-43.4%
52.2%
Q2 25
-24.5%
Q1 25
-2.7%
Q4 24
-26.1%
Q3 24
-26.5%
Q2 24
-23.0%
Q1 24
-23.7%
Net Margin
DHC
DHC
IDYA
IDYA
Q4 25
-5.6%
Q3 25
-42.2%
57.4%
Q2 25
-23.9%
Q1 25
-2.3%
Q4 24
-23.0%
Q3 24
-26.4%
Q2 24
-26.3%
Q1 24
-23.3%
EPS (diluted)
DHC
DHC
IDYA
IDYA
Q4 25
$-0.09
Q3 25
$-0.68
$1.33
Q2 25
$-0.38
Q1 25
$-0.04
Q4 24
$-0.37
Q3 24
$-0.41
$-0.60
Q2 24
$-0.41
$-0.68
Q1 24
$-0.36
$-0.53

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DHC
DHC
IDYA
IDYA
Cash + ST InvestmentsLiquidity on hand
$105.4M
$786.9M
Total DebtLower is stronger
$2.4B
Stockholders' EquityBook value
$1.7B
$1.1B
Total Assets
$4.4B
$1.2B
Debt / EquityLower = less leverage
1.47×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DHC
DHC
IDYA
IDYA
Q4 25
$105.4M
Q3 25
$201.4M
$786.9M
Q2 25
$141.8M
Q1 25
$302.6M
Q4 24
$144.6M
Q3 24
$256.5M
$920.0M
Q2 24
$265.6M
$701.7M
Q1 24
$207.1M
$698.8M
Total Debt
DHC
DHC
IDYA
IDYA
Q4 25
$2.4B
Q3 25
Q2 25
Q1 25
Q4 24
$3.1B
Q3 24
Q2 24
Q1 24
Stockholders' Equity
DHC
DHC
IDYA
IDYA
Q4 25
$1.7B
Q3 25
$1.7B
$1.1B
Q2 25
$1.9B
Q1 25
$1.9B
Q4 24
$2.0B
Q3 24
$2.0B
$1.2B
Q2 24
$2.1B
$931.7M
Q1 24
$2.2B
$935.3M
Total Assets
DHC
DHC
IDYA
IDYA
Q4 25
$4.4B
Q3 25
$4.7B
$1.2B
Q2 25
$4.8B
Q1 25
$5.0B
Q4 24
$5.1B
Q3 24
$5.3B
$1.2B
Q2 24
$5.3B
$973.7M
Q1 24
$5.3B
$961.5M
Debt / Equity
DHC
DHC
IDYA
IDYA
Q4 25
1.47×
Q3 25
Q2 25
Q1 25
Q4 24
1.56×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DHC
DHC
IDYA
IDYA
Operating Cash FlowLast quarter
$-19.6M
$142.2M
Free Cash FlowOCF − Capex
$-166.4M
$142.2M
FCF MarginFCF / Revenue
-43.8%
68.4%
Capex IntensityCapex / Revenue
38.7%
0.0%
Cash ConversionOCF / Net Profit
1.19×
TTM Free Cash FlowTrailing 4 quarters
$-280.3M
$13.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DHC
DHC
IDYA
IDYA
Q4 25
$-19.6M
Q3 25
$-49.3M
$142.2M
Q2 25
$53.0M
Q1 25
$-3.2M
Q4 24
$112.2M
Q3 24
$21.1M
$-49.2M
Q2 24
$44.3M
$-32.9M
Q1 24
$28.6M
$-43.8M
Free Cash Flow
DHC
DHC
IDYA
IDYA
Q4 25
$-166.4M
Q3 25
$-89.8M
$142.2M
Q2 25
$18.8M
Q1 25
$-42.9M
Q4 24
$-89.5M
Q3 24
$-26.1M
$-49.7M
Q2 24
$3.3M
$-33.9M
Q1 24
$-18.1M
$-45.1M
FCF Margin
DHC
DHC
IDYA
IDYA
Q4 25
-43.8%
Q3 25
-23.1%
68.4%
Q2 25
4.9%
Q1 25
-11.1%
Q4 24
-23.6%
Q3 24
-7.0%
Q2 24
0.9%
Q1 24
-4.9%
Capex Intensity
DHC
DHC
IDYA
IDYA
Q4 25
38.7%
Q3 25
10.4%
0.0%
Q2 25
8.9%
Q1 25
10.2%
Q4 24
53.1%
Q3 24
12.6%
Q2 24
11.0%
Q1 24
12.6%
Cash Conversion
DHC
DHC
IDYA
IDYA
Q4 25
Q3 25
1.19×
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

DHC
DHC

Senior Housing Operating Portfolio Segment$323.4M85%
Rental Income$56.2M15%

IDYA
IDYA

Segment breakdown not available.

Related Comparisons